OPTIRAY 320 Drug Patent Profile
✉ Email this page to a colleague
When do Optiray 320 patents expire, and when can generic versions of Optiray 320 launch?
Optiray 320 is a drug marketed by Liebel-flarsheim and is included in two NDAs.
The generic ingredient in OPTIRAY 320 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.
Summary for OPTIRAY 320
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 2,047 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPTIRAY 320 at DailyMed |
Recent Clinical Trials for OPTIRAY 320
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Duke Clinical Research Institute | Phase 4 |
GE Healthcare | Phase 4 |
Bayer | Phase 4 |
Pharmacology for OPTIRAY 320
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for OPTIRAY 320
US Patents and Regulatory Information for OPTIRAY 320
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 320 | ioversol | INJECTABLE;INJECTION | 019710-001 | Dec 30, 1988 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Liebel-flarsheim | OPTIRAY 320 | ioversol | INJECTABLE;INJECTION | 020923-002 | May 29, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OPTIRAY 320
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 320 | ioversol | INJECTABLE;INJECTION | 019710-001 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Liebel-flarsheim | OPTIRAY 320 | ioversol | INJECTABLE;INJECTION | 020923-002 | May 29, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OPTIRAY 320
See the table below for patents covering OPTIRAY 320 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S58131970 | COMPOUND | ⤷ Try a Trial |
Netherlands | 930067 | ⤷ Try a Trial | |
Australia | 552188 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OPTIRAY 320
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0083964 | SPC/GB93/089 | United Kingdom | ⤷ Try a Trial | SPC/GB93/089: 20041015 |
0083964 | 93C0142 | Belgium | ⤷ Try a Trial | PRODUCT NAME: IOVERSOL; NAT. REGISTRATION NO/DATE: 74 IS 56 F12/19910521; FIRST REGISTRATION: NL RVG 13345 19891016 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |